Hypercalcemia clinical trials
The registry lists 42 studies for Hypercalcemia across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18.
Status
- Completed
- 20
- Status unknown
- 7
- Recruiting
- 6
- Withdrawn
- 4
- Terminated
- 3
- Enrolling by invitation
- 1
Phase
- Phase 3
- 10
- Phase 2
- 10
- Phase 4
- 4
- Phase 1
- 4
- Early Phase 1
- 1
Where
- United States
- 18
- Denmark
- 5
- Canada
- 3
- Italy
- 2
- Israel
- 2
- United Kingdom
- 2
Who runs them
Martin Blomberg Jensen (3) · University of Pittsburgh (2) · Kyowa Kirin Co., Ltd. (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Columbia University (1) · Sun Yat-sen University (1) · Children's Hospital of Philadelphia (1) · Peerbridge Health, Inc (1)
Studies
Recruiting first, then most recently updated. Showing 42 of 42 — search for more.
- The GranStone TrialNot yet recruitingNCT07828002Phase 2/31 country
- Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine DisordersRecruitingNCT078241021 country
- Rifampin in CYP24A1-related Hypercalcemia and HypercalciuriaRecruitingNCT03301038Phase 21 country
- Hypercalcemia After Paraffin Oil InjectionRecruitingNCT042922881 country
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling by invitationNCT067635491 country
- Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of ParaffinoilRecruitingNCT042655991 country
- Calcitonin Pre-treatment to Improve SPECT-CT SensitivityRecruitingNCT03935984Phase 41 country
- Registry for Hypoparathyroidism WuerzburgRecruitingNCT055855931 country
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT05152927Not applicable1 country
- Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT05022641Not applicable1 country
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedNCT00415584Phase 1/21 country
- Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT04299425Not applicable1 country
- Familial Hypocalciuric Hypercalcemia: Clinical Aspects and EvolutionCompletedNCT048728941 country
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 41 country
- Does Treatment of Hypovitaminosis D Increase Calcium Absorption?CompletedNCT00581828Phase 41 country
- Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 21 country
- Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneTerminatedNCT00458796Not applicable1 country
- Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum ElectrolytesCompletedNCT042563691 country
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIHStatus unknownNCT03384121Phase 11 country
- Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes PanelCompletedNCT029085421 country
- Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary HyperparathyroidismCompletedNCT03280264Phase 31 country
- Insulin Resistance in Primary HyperparathyroidismWithdrawnNCT02711059Not applicable1 country
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 25 countries
- Cinacalcet to Treat Familial Primary HyperparathyroidismCompletedNCT00325104Phase 31 country
- Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor MutationsStatus unknownNCT02023489Not applicable1 country
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 31 country
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation StudyCompletedNCT00580788Early Phase 11 country
- Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.CompletedNCT00744302Phase 21 country
- Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin DWithdrawnNCT01329666Phase 2/31 country
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot StudyStatus unknownNCT02155803Phase 2/31 country
- One Week Comparison Study of PTH and PTHrP InfusionsWithdrawnNCT01333267Phase 11 country
- Differentially Expressed Proteins in Sporadic Parathyroid TumorsStatus unknownNCT016475031 country
- Effect of Vitamin D Treatment in Primary HyperparathyroidismCompletedNCT00674154Phase 2/31 country
- S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
- Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone MetastasesCompletedNCT00060138Phase 1/21 country
- Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerStatus unknownNCT00326820Phase 31 country
- Zoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneCompletedNCT00003884Phase 31 country
- Parathyroid Hormone (PTH) Homeostasis in Bartter SyndromeStatus unknownNCT010212801 country
- Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the CommunityCompletedNCT00126386Not applicable1 country
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 41 country
- The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to ExplorationStatus unknownNCT012268101 country
- Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy SubjectsCompletedNCT01042626Not applicable1 country